Analytical comparison of over-the-counter multiplex tests for influenza A, influenza B and SARS-CoV-2

2025-12-30 infectious diseases Title + abstract only

Show abstract

Over-the-counter (OTC) lateral flow tests for respiratory viruses have newly emerged since the beginning of the coronavirus disease 2019 (COVID-19) pandemic and are increasingly available to consumers. While all marketed tests have met standards for Emergency Use Authorization (EUA), De Novo classification or 510(k) clearance, limited data are available to inform consumers of their relative performance. We performed a head-to-head benchtop analytical assessment of OTC tests available for purchas...

Analytical comparison of over-the-counter multiplex tests for influenza A, influenza B and SARS-CoV-2

Predicted journal destinations